These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Albillos A, García-Pagán JC, Iborra J, Bandi JC, Cacho G, Pérez-Paramo M, Escorsell A, Calleja JL, Escartín P, Bosch J. Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466 [Abstract] [Full Text] [Related]
7. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients. Stanley AJ, Bouchier IA, Hayes PC. Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956 [Abstract] [Full Text] [Related]
8. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events]. Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B. Gastroenterol Hepatol; 2000 Feb; 23(6):275-81. PubMed ID: 15324622 [Abstract] [Full Text] [Related]
9. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis. Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J. J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728 [Abstract] [Full Text] [Related]
10. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function. Ikegami M, Toyonaga A, Tanikawa K. Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573 [Abstract] [Full Text] [Related]
12. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, Angeli P, Gatta A. Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449 [Abstract] [Full Text] [Related]
13. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. García-Pagán JC, Feu F, Bosch J, Rodés J. Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947 [Abstract] [Full Text] [Related]
15. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis. Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ. Hepatology; 1989 Sep 15; 10(3):283-7. PubMed ID: 2759546 [Abstract] [Full Text] [Related]
18. The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis. Albillos A, Bañares R, González M, Catalina MV, Pastor O, Gonzalez R, Ripoll C, Bosch J. Gut; 2007 Feb 15; 56(2):259-64. PubMed ID: 16837532 [Abstract] [Full Text] [Related]